Literature DB >> 10424676

Effects of BDNF and NT-3 on hair cell survival in guinea pig cochlea damaged by kanamycin treatment.

R S Ruan1, S K Leong, I Mark, K H Yeoh.   

Abstract

The aim of this study was to determine whether neurotrophic factors such as brain derived neurotrophic factor (BDNF) and neurotrophin 3 (NT-3) would protect auditory hair cells from ototoxicity by aminoglycoside antibiotic. Twenty-seven Wistar guinea pigs were divided into three groups of nine animals each. BDNF and NT-3 (100 microg/ml) were delivered into the right scala tympani of guinea pig cochlea through a cannula-osmotic pump device. Artificial perilymph (AP) was used as control. Immediately after implantation of the device, each animal was given five successive doses of kanamycin (400 mg/kg). At 15, 30 and 60 days after infusion, surviving inner and outer hair cells were counted at each turn of every cochlea with a Philips 515 scanning electron microscope. Multiple comparison tests were carried out among the groups, using ANOVA and Dunnett T3/Tukey HSD. Protective effects of NT-3 on hair cells were observed at 30 and 60 days after kanamycin injection. BDNF had no protective effect on hair cells at 15 and 60 days, but some at 30 days. This study suggests that NT-3 and BDNF may protect against cochlear hair cell damage caused by kanamycin treatment. Possible mechanisms for the otoprotective effects were discussed. No single mechanism postulated can explain fully the results seen in this study. It is possible that the mechanisms act in concert to produce the observed effects, or there are as yet undiscovered mechanisms or secondary messengers responsible for the otoprotective effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10424676     DOI: 10.1097/00001756-199907130-00014

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  15 in total

1.  Rescue of hearing, auditory hair cells, and neurons by CEP-1347/KT7515, an inhibitor of c-Jun N-terminal kinase activation.

Authors:  U Pirvola; L Xing-Qun; J Virkkala; M Saarma; C Murakata; A M Camoratto; K M Walton; J Ylikoski
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

2.  Otoprotective effects of mouse nerve growth factor in DBA/2J mice with early-onset progressive hearing loss.

Authors:  Qingzhu Wang; Hongchun Zhao; Tihua Zheng; Wenjun Wang; Xiaolin Zhang; Andi Wang; Bo Li; Yanfei Wang; Qingyin Zheng
Journal:  J Neurosci Res       Date:  2017-03-27       Impact factor: 4.164

3.  Aminoglycoside Increases Permeability of Osseous Spiral Laminae of Cochlea by Interrupting MMP-2 and MMP-9 Balance.

Authors:  Dengke Li; Jianhe Sun; Lidong Zhao; Weiwei Guo; Wei Sun; Shiming Yang
Journal:  Neurotox Res       Date:  2016-12-22       Impact factor: 3.911

4.  Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons.

Authors:  Rachael T Richardson; Andrew K Wise; Brianna C Thompson; Brianna O Flynn; Patrick J Atkinson; Nicole J Fretwell; James B Fallon; Gordon G Wallace; Rob K Shepherd; Graeme M Clark; Stephen J O'Leary
Journal:  Biomaterials       Date:  2009-01-29       Impact factor: 12.479

5.  Lipid nanoparticles-encapsulated brain-derived neurotrophic factor mRNA delivered through the round window niche in the cochleae of guinea pigs.

Authors:  Toru Miwa; Haruki Saito; Hidetaka Akita
Journal:  Exp Brain Res       Date:  2020-11-19       Impact factor: 1.972

6.  Effects of localized neurotrophin gene expression on spiral ganglion neuron resprouting in the deafened cochlea.

Authors:  Andrew K Wise; Clifford R Hume; Brianna O Flynn; Yogesh S Jeelall; Courtney L Suhr; Beatrice E Sgro; Stephen J O'Leary; Robert K Shepherd; Rachael T Richardson
Journal:  Mol Ther       Date:  2010-03-09       Impact factor: 11.454

7.  Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection.

Authors:  M E Huth; A J Ricci; A G Cheng
Journal:  Int J Otolaryngol       Date:  2011-10-25

Review 8.  Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness.

Authors:  Igor Khalin; Renad Alyautdin; Ganna Kocherga; Muhamad Abu Bakar
Journal:  Int J Nanomedicine       Date:  2015-04-30

9.  Viability of long-term gene therapy in the cochlea.

Authors:  Patrick J Atkinson; Andrew K Wise; Brianna O Flynn; Bryony A Nayagam; Rachael T Richardson
Journal:  Sci Rep       Date:  2014-04-22       Impact factor: 4.379

10.  Attenuation of noise-induced hearing loss using methylene blue.

Authors:  J-S Park; I Jou; S M Park
Journal:  Cell Death Dis       Date:  2014-04-24       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.